Sign In
Buy AGEN
$3.07
+0.0300 (+0.99%)
At Close: Jun 23, 2026
Why Agenus Stock Is Popping Today
02:39pm, Monday, 02'nd Nov 2020
An off-the-shelf cell therapy for COVID-19 is sending the biotech's shares higher today.
Agenus Doses First COVID-19 Patient with iNKT Cell Therapy
08:45am, Monday, 02'nd Nov 2020
LEXINGTON, Mass., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of agents designed to activate immune response to cancers and infe
Agenus Inc. (AGEN) CEO Garo Armen on Q3 2020 Results - Earnings Call Transcript
04:02pm, Thursday, 29'th Oct 2020
Agenus Inc. (AGEN) CEO Garo Armen on Q3 2020 Results - Earnings Call Transcript
Agenus R&D Update & Third Quarter Financial Report
07:45am, Thursday, 29'th Oct 2020
LEXINGTON, Mass., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines
Exclusive: U.S. trial of AstraZeneca COVID-19 vaccine may resume this week - sources
12:00am, Tuesday, 20'th Oct 2020
Exclusive: U.S. trial of AstraZeneca COVID-19 vaccine may resume this week - sources
Remdesivir has ‘little or no effect’ in reducing coronavirus deaths, WHO says
12:48pm, Friday, 16'th Oct 2020
A study coordinated by the World Health Organization has indicated that remdesivir, along with three other potential drug treatments for the coronavirus, has "little or no effect" on death rates among
Ad-Tech And Perion Are Coming Back, Fast (NASDAQ:PERI)
12:47pm, Friday, 09'th Oct 2020
Perion Network's three-pronged approach is starting to deliver, just when the digital advertising industry is showing signs of stability after suffering one of worth downturns due to COVID-19.
Critical Review: Agenus (NASDAQ:AGEN) and Repligen (NASDAQ:RGEN)
02:18am, Friday, 25'th Sep 2020
Agenus (NASDAQ:AGEN) and Repligen (NASDAQ:RGEN) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, profitab
Engagement with anti-vaccine Facebook posts trebles in one month
05:00am, Saturday, 19'th Sep 2020
Exclusive: Guardian analysis prompts calls for new drive to combat conspiracy theories
Silver Bulls Will Be Handsomely Rewarded
02:51pm, Wednesday, 16'th Sep 2020
Silver will outpace gold, surprising even the most ardent bulls. Silver's monetary characteristics will dominate, making investment its biggest demand driver.
Interim Data Reported for AbCellera-Discovered COVID-19 Antibody in Phase 2 Clinical Trials
12:00am, Wednesday, 16'th Sep 2020
Interim data from a Phase 2 clinical trial of LY-CoV555 shows a reduction in the rate of hospitalization in patients treated with the antibody.
2021 Assembly elections: Adhir says poll tie-up with Left need of hour
05:42am, Friday, 11'th Sep 2020
The CPM responded in favour of an alliance with the Congress, emphasising that uniting anti-TMC and anti-BJP forces was the need of the hour.
Oncology Stocks Are Trading Materially Lower The Last 2 Months
12:00pm, Monday, 24'th Aug 2020
Of a pool of 26 oncology stocks we track, with 1 exception, all (literally 25 of 26) are trading materially lower from the third week of June 2020.
Plasma Treatment For COVID-19 Unlikely To Be 'Home Run,' Says Ex-FDA Commissioner
12:00am, Monday, 24'th Aug 2020
The FDA granted emergency authorization of convalescent plasma to treat hospitalized COVID-19 patients on Sunday, and this could be helpful in treating sick people, former...
